Nifty

:

23850.90

Sensex

:

78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Login

Nifty
Sensex

:
:

23850.90
78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Medplus Health Services Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543427 | NSE: MEDPLUS

Watchlist

NSE BSE

669.30

05-Jul-2024

Open
High
Low
Previous Close

691.00
691.00
663.10
689.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3563085
24183.44
849.00
598.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,005.48
105.27
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,863.79
N/A
5.12

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
14.40
14.17

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
22.67
5.15

PAT CAGR (%)

10 Years
5 Years
3 Years

-
105.42
-11.92

P:E (Median)

8 Years
5 Years
3 Years

-
-
164.90

P:BV (Average)

8 Years
5 Years
3 Years

-
-
6.69

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
29.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 178.33 71.89 148.06% 148.37 86.95 70.64% 148.10 57.24 158.74% 98.67 42.45 132.44%
Expenses 159.98 69.57 129.96% 135.43 75.53 79.31% 137.31 53.50 156.65% 92.40 42.88 115.49%
EBITDA 18.34 2.32 690.52% 12.94 11.42 13.31% 10.79 3.74 188.50% 6.27 -0.42 -
EBIDTM 10.29% 3.23% 8.72% 13.13% 7.29% 6.54% 6.36% -1.00%
Other Income 1.84 1.81 1.66% 1.90 2.54 -25.20% 1.82 4.07 -55.28% 1.76 4.26 -58.69%
Interest 2.10 2.08 0.96% 2.11 2.05 2.93% 2.10 1.79 17.32% 2.11 1.46 44.52%
Depreciation 6.47 5.54 16.79% 6.40 5.33 20.08% 6.27 4.24 47.88% 5.96 3.20 86.25%
PBT 11.61 -3.49 - 6.32 6.59 -4.10% 4.24 1.78 138.20% -0.04 -0.82 -
Tax 2.35 0.00 0 -3.59 0.88 - 1.05 1.16 -9.48% 0.00 0.00 0
PAT 9.26 -3.49 - 9.92 5.71 73.73% 3.19 0.62 414.52% -0.04 -0.82 -
PATM 5.19% -4.85% 6.68% 6.56% 2.15% 1.08% -0.04% -1.93%
EPS 0.77 -0.29 - 0.83 0.48 72.92% 0.27 0.05 440.00% 0.00 -0.07 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 1,488.83 1,284.30 15.93% 1,490.50 1,252.98 18.96% 1,441.47 1,190.31 21.10% 1,408.59 1,120.63 25.70%
Expenses 1,395.06 1,212.95 15.01% 1,384.63 1,171.35 18.21% 1,349.69 1,118.59 20.66% 1,323.50 1,060.96 24.75%
EBITDA 93.76 71.34 31.43% 105.87 81.63 29.69% 91.78 71.72 27.97% 85.09 59.67 42.60%
EBIDTM 6.30% 5.56% 7.10% 6.51% 6.37% 6.03% 6.04% 5.32%
Other Income 8.71 9.39 -7.24% 10.46 13.69 -23.59% 9.79 11.36 -13.82% 10.37 10.89 -4.78%
Interest 24.66 23.27 5.97% 25.13 22.27 12.84% 24.50 21.08 16.22% 23.54 19.87 18.47%
Depreciation 60.03 52.41 14.54% 59.21 55.80 6.11% 57.11 45.79 24.72% 55.47 41.87 32.48%
PBT 17.79 5.05 252.28% 31.99 17.25 85.45% 19.96 16.21 23.13% 16.44 8.82 86.39%
Tax 3.44 1.29 166.67% -1.58 -9.30 - 6.26 2.83 121.20% 1.90 2.34 -18.80%
PAT 14.34 3.76 281.38% 33.56 26.56 26.36% 13.71 13.38 2.47% 14.54 6.48 124.38%
PATM 0.96% 0.29% 2.25% 2.12% 0.95% 1.12% 1.03% 0.58%
EPS 1.20 0.32 275.00% 2.79 2.23 25.11% 1.15 1.12 2.68% 1.22 0.55 121.82%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 573.47 467.03 213.93 145.71 68.31 61.11 2.55 2.59 3.04 382.11 292.66 Net Sales Growth 121.82% 118.31% 46.82% 113.31% 11.78% 2296.47% -1.54% -14.80% -99.20% 30.56% Cost Of Goods Sold 438.57 351.04 156.87 118.57 50.24 43.53 0.00 0.00 0.00 0.00 0.00 Gross Profit 134.90 116.00 57.05 27.15 18.08 17.59 2.55 2.59 3.04 382.11 292.66 GP Margin 23.52% 24.84% 26.67% 18.63% 26.47% 28.78% 100% 100% 100% 100% 100% Total Expenditure 525.12 434.71 207.67 142.41 77.11 86.29 4.14 4.25 6.81 383.54 313.26 Power & Fuel Cost - 4.70 2.57 0.57 0.18 0.06 0.00 0.00 0.00 0.00 0.00 % Of Sales - 1.01% 1.20% 0.39% 0.26% 0.10% 0% 0% 0% 0% 0% Employee Cost - 43.61 28.14 13.73 22.57 6.91 0.00 0.00 0.00 0.00 0.00 % Of Sales - 9.34% 13.15% 9.42% 33.04% 11.31% 0% 0% 0% 0% 0% Manufacturing Exp. - 5.20 1.45 0.51 0.32 1.69 0.00 0.00 0.00 0.00 0.00 % Of Sales - 1.11% 0.68% 0.35% 0.47% 2.77% 0% 0% 0% 0% 0% General & Admin Exp. - 20.34 11.34 4.92 3.48 1.70 4.14 4.25 6.81 383.54 313.26 % Of Sales - 4.36% 5.30% 3.38% 5.09% 2.78% 162.35% 164.09% 224.01% 100.37% 107.04% Selling & Distn. Exp. - 7.83 6.28 3.41 0.07 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 1.68% 2.94% 2.34% 0.10% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 2.00 1.00 0.70 0.26 32.41 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.43% 0.47% 0.48% 0.38% 53.04% 0% 0% 0% 0% 0% EBITDA 48.34 32.32 6.26 3.30 -8.80 -25.18 -1.59 -1.66 -3.77 -1.43 -20.60 EBITDA Margin 8.43% 6.92% 2.93% 2.26% -12.88% -41.20% -62.35% -64.09% -124.01% -0.37% -7.04% Other Income 7.32 7.29 23.18 9.54 2.11 1.92 0.22 0.47 1.81 2.43 2.89 Interest 8.42 8.40 6.54 2.63 0.56 0.27 1.93 0.51 0.16 0.84 0.00 Depreciation 25.10 24.17 15.31 4.63 1.31 0.84 0.24 0.28 0.33 1.00 1.51 PBT 22.13 7.04 7.59 5.58 -8.57 -24.36 -3.54 -1.99 -2.45 -0.83 -19.22 Tax -0.19 -2.54 2.04 0.00 0.00 0.51 0.00 0.00 0.00 0.00 -0.47 Tax Rate -0.86% -36.08% 26.88% 0.00% 0.00% -2.09% 0.00% 0.00% 0.00% 0.00% 2.45% PAT 22.33 9.58 5.54 5.58 -8.57 -24.87 -7.09 -1.99 -2.45 -8.06 -18.75 PAT before Minority Interest 22.33 9.58 5.54 5.58 -8.57 -24.87 -7.09 -1.99 -2.45 -8.06 -18.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.89% 2.05% 2.59% 3.83% -12.55% -40.70% -278.04% -76.83% -80.59% -2.11% -6.41% PAT Growth 1,005.45% 72.92% -0.72% - - - - - - - EPS 1.87 0.80 0.46 0.47 -0.72 -2.08 -0.59 -0.17 -0.21 -0.67 -1.57

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 5,829.39 5,624.85 4,557.58 3,779.28 3,069.27 2,870.60 Net Sales Growth 20.24% 23.42% 20.59% 23.13% 6.92% Cost Of Goods Sold 4,540.31 4,391.63 3,557.69 2,982.37 2,425.24 2,336.54 Gross Profit 1,289.08 1,233.23 999.89 796.90 644.03 534.07 GP Margin 22.11% 21.92% 21.94% 21.09% 20.98% 18.60% Total Expenditure 5,452.88 5,253.56 4,276.21 3,490.40 2,840.05 2,736.93 Power & Fuel Cost - 45.50 31.71 17.78 13.29 13.70 % Of Sales - 0.81% 0.70% 0.47% 0.43% 0.48% Employee Cost - 625.52 545.13 393.92 338.65 272.40 % Of Sales - 11.12% 11.96% 10.42% 11.03% 9.49% Manufacturing Exp. - 9.11 6.19 4.57 6.18 8.28 % Of Sales - 0.16% 0.14% 0.12% 0.20% 0.29% General & Admin Exp. - 76.56 62.06 39.66 24.88 21.00 % Of Sales - 1.36% 1.36% 1.05% 0.81% 0.73% Selling & Distn. Exp. - 98.28 67.76 47.35 29.27 47.58 % Of Sales - 1.75% 1.49% 1.25% 0.95% 1.66% Miscellaneous Exp. - 6.96 5.67 4.75 2.54 37.43 % Of Sales - 0.12% 0.12% 0.13% 0.08% 1.30% EBITDA 376.50 371.29 281.37 288.88 229.22 133.67 EBITDA Margin 6.46% 6.60% 6.17% 7.64% 7.47% 4.66% Other Income 39.33 40.01 46.08 31.36 21.55 17.28 Interest 97.83 113.65 98.72 82.94 67.40 46.80 Depreciation 231.82 224.21 181.56 119.36 88.27 74.81 PBT 86.18 73.44 47.16 117.94 95.10 29.36 Tax 10.02 7.87 -2.94 23.23 31.99 27.57 Tax Rate 11.63% 10.72% -6.23% 19.70% 33.64% 93.90% PAT 76.15 65.48 49.76 95.81 63.86 1.79 PAT before Minority Interest 76.05 65.58 50.10 94.72 63.11 1.79 Minority Interest -0.10 -0.10 -0.34 1.09 0.75 0.00 PAT Margin 1.31% 1.16% 1.09% 2.54% 2.08% 0.06% PAT Growth 51.75% 31.59% -48.06% 50.03% 3,467.60% EPS 6.37 5.48 4.16 8.02 5.34 0.15

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 1,172.63 1,141.28 1,112.78 517.48 395.61 135.10 142.19 144.18 146.48 93.78 Share Capital 23.91 23.86 23.86 0.45 0.19 0.17 0.17 0.17 0.17 0.15 Total Reserves 1,118.36 1,086.98 1,077.53 468.38 159.28 130.40 137.50 139.49 141.93 88.58 Non-Current Liabilities 82.24 84.69 42.40 7.34 3.45 0.08 0.08 0.07 0.00 15.77 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.77 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.39 3.88 0.71 0.88 1.10 0.08 0.08 0.07 0.00 0.00 Current Liabilities 55.85 48.01 32.27 23.60 16.17 10.77 9.32 1.15 5.69 29.52 Trade Payables 17.95 12.79 5.53 2.36 1.11 0.73 0.75 1.01 2.74 25.21 Other Current Liabilities 35.98 34.19 26.01 20.58 14.61 0.18 0.37 0.11 2.79 3.92 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 8.00 8.00 0.00 0.00 0.00 Short Term Provisions 1.92 1.03 0.74 0.66 0.45 1.85 0.20 0.02 0.16 0.39 Total Liabilities 1,310.72 1,273.98 1,187.45 548.42 415.23 145.95 151.59 145.40 152.17 139.07 Net Block 191.68 179.41 85.02 22.68 7.17 1.19 1.57 1.98 2.38 4.86 Gross Block 236.81 201.26 92.46 25.91 9.21 2.18 2.36 2.64 2.72 6.31 Accumulated Depreciation 45.13 21.85 7.45 3.23 2.04 0.99 0.80 0.66 0.34 1.46 Non Current Assets 1,134.79 1,123.40 530.12 441.94 390.32 145.54 147.55 142.72 105.85 6.70 Capital Work in Progress 0.35 17.91 15.52 2.01 0.95 0.00 0.00 0.00 0.00 0.31 Non Current Investment 929.72 917.16 418.45 408.50 381.09 143.63 145.33 139.48 103.48 1.54 Long Term Loans & Adv. 8.04 8.92 11.13 8.75 1.12 0.71 0.65 1.25 0.00 0.00 Other Non Current Assets 5.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 Current Assets 175.93 150.58 657.34 106.48 24.90 0.40 4.04 2.68 46.32 132.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 13.96 6.69 3.90 4.79 3.94 0.12 0.12 0.12 0.15 20.50 Sundry Debtors 65.83 37.61 21.29 11.51 8.60 0.14 0.13 0.09 0.15 84.48 Cash & Bank 62.43 90.16 7.44 86.68 10.74 0.03 2.16 2.43 28.62 5.88 Other Current Assets 33.70 1.32 21.57 0.41 1.63 0.11 1.63 0.05 17.40 21.52 Short Term Loans & Adv. 31.48 14.81 603.14 3.10 1.30 0.11 1.62 0.03 16.92 17.91 Net Current Assets 120.08 102.57 625.06 82.88 8.73 -10.36 -5.28 1.53 40.63 102.85 Total Assets 1,310.72 1,273.98 1,187.46 548.42 415.22 145.94 151.59 145.40 152.17 139.07

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 1,577.93 1,491.18 1,417.77 730.55 527.80 Share Capital 23.91 23.86 23.86 0.45 0.19 Total Reserves 1,523.66 1,436.88 1,382.52 681.45 291.47 Non-Current Liabilities 839.74 797.40 647.39 381.01 298.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 55.71 61.33 94.94 18.35 17.74 Current Liabilities 525.93 476.58 559.01 444.84 481.09 Trade Payables 253.03 260.14 246.23 148.09 234.15 Other Current Liabilities 241.81 189.35 148.29 111.39 122.35 Short Term Borrowings 0.00 0.00 142.68 135.24 105.05 Short Term Provisions 31.09 27.09 21.80 50.12 19.54 Total Liabilities 2,943.03 2,764.48 2,623.65 1,556.95 1,308.54 Net Block 1,241.83 1,137.96 798.73 517.30 419.46 Gross Block 1,861.94 1,615.62 1,114.11 739.16 689.67 Accumulated Depreciation 620.11 477.66 315.38 221.86 270.21 Non Current Assets 1,375.48 1,283.77 991.95 603.97 492.76 Capital Work in Progress 11.08 25.47 20.45 5.54 4.94 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 116.72 120.19 172.75 81.08 68.33 Other Non Current Assets 5.85 0.15 0.02 0.05 0.04 Current Assets 1,567.55 1,480.72 1,631.71 952.98 815.78 Current Investments 0.00 0.03 0.03 0.03 0.25 Inventories 1,340.23 1,144.09 914.98 749.96 643.55 Sundry Debtors 17.50 8.65 6.04 5.37 6.40 Cash & Bank 141.68 283.83 34.41 118.59 140.69 Other Current Assets 68.13 9.91 31.74 7.69 24.87 Short Term Loans & Adv. 53.84 34.20 644.51 71.34 18.16 Net Current Assets 1,041.62 1,004.14 1,072.70 508.14 334.69 Total Assets 2,943.03 2,764.49 2,623.66 1,556.95 1,308.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 7.67 11.40 -18.37 -6.24 2.89 -1.80 -0.64 -5.61 -4.05 -6.89 PBT 7.04 7.59 5.58 -8.57 -24.36 -7.09 -1.99 -2.45 -8.06 -19.22 Adjustment 31.11 3.39 0.65 8.22 31.25 0.16 0.03 -0.83 8.71 7.53 Changes in Working Capital -28.16 2.24 -22.59 -6.17 -4.79 -0.18 0.43 -3.86 -4.71 4.81 Cash after chg. in Working capital 9.99 13.22 -16.36 -6.52 2.10 -7.11 -1.53 -7.13 -4.05 -6.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 1.93 0.51 0.00 0.00 0.00 Tax Paid -2.32 -1.81 -2.01 0.28 0.79 -0.21 0.29 1.52 0.00 -0.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 3.59 0.09 0.00 0.00 0.00 Cash From Investing Activity -24.43 31.72 -635.99 -14.77 -196.64 1.54 -7.14 -20.40 -11.10 0.71 Net Fixed Assets -17.99 -111.19 -80.06 -17.76 -7.98 0.18 0.28 0.08 3.90 3.24 Net Investments -12.56 -498.71 -9.95 -27.41 -237.46 1.70 -5.85 -36.00 -101.94 -1.51 Others 6.12 641.62 -545.98 30.40 48.80 -0.34 -1.57 15.52 86.94 -1.02 Cash from Financing Activity -5.95 -8.36 568.63 96.94 203.96 -1.87 7.51 -0.16 43.39 6.25 Net Cash Inflow / Outflow -22.70 34.77 -85.74 75.94 10.21 -2.13 -0.27 -26.18 28.24 0.07 Opening Cash & Equivalents 35.70 0.94 86.68 10.74 0.53 2.16 2.43 28.61 0.37 0.31 Closing Cash & Equivalent 13.00 35.70 0.94 86.68 10.74 0.03 2.16 2.43 28.61 0.37

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 143.74 90.41 169.89 2.89 -6.59 PBT 73.44 47.16 117.94 95.10 29.36 Adjustment 330.62 272.76 187.88 182.28 155.41 Changes in Working Capital -231.10 -215.58 -102.37 -245.77 -176.50 Cash after chg. in Working capital 172.96 104.34 203.45 31.61 8.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -29.22 -13.94 -33.56 -28.71 -14.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -82.80 429.44 -703.13 -34.55 -27.55 Net Fixed Assets -17.99 -111.19 -80.06 -17.76 Net Investments -12.56 -498.71 -9.95 -27.41 Others -52.25 1,039.34 -613.12 10.62 Cash from Financing Activity -198.10 -170.25 440.43 -5.63 89.83 Net Cash Inflow / Outflow -137.17 349.60 -92.81 -37.28 55.69 Opening Cash & Equivalents 228.38 -121.23 -28.42 8.87 -46.82 Closing Cash & Equivalent 91.21 228.38 -121.23 -28.42 8.87

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 95.56 93.11 92.32 2092.97 8220.31 7761.29 8182.90 8301.20 8446.76 5835.11 ROA 0.74% 0.45% 0.64% -1.78% -8.20% -4.77% -1.34% -1.65% -5.53% -13.59% ROE 0.85% 0.50% 0.71% -2.73% -14.80% -5.29% -1.44% -1.74% -6.98% -19.11% ROCE 1.33% 1.25% 1.01% -1.75% -8.30% -3.52% -1.00% -1.57% -5.64% -17.04% Fixed Asset Turnover 2.31 1.57 2.63 3.98 11.59 1.12 1.03 1.13 84.62 37.78 Receivable days 37.37 46.56 38.38 52.46 31.88 19.40 15.57 14.06 40.42 104.89 Inventory Days 7.46 8.37 10.16 22.76 12.43 17.35 16.63 16.21 9.87 23.98 Payable days 15.98 21.31 12.15 12.61 22.26 1130.61 1132.69 2107.52 5120.81 4171.22 Cash Conversion Cycle 28.85 33.62 36.39 62.61 22.06 -1093.85 -1100.48 -2077.26 -5070.53 -4042.34 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.00 0.00 0.18 Interest Cover 1.84 2.16 3.12 -14.16 -89.56 -2.67 -2.89 -14.12 -8.62 0.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 129.47 122.44 117.89 3044.19 15034.43 ROA 2.30% 1.86% 4.51% 4.40% 0.18% ROE 4.36% 3.50% 9.07% 12.96% 0.59% ROCE 12.19% 9.56% 16.56% 21.69% 14.34% Fixed Asset Turnover 3.28 3.39 4.13 4.38 6.75 Receivable days 0.84 0.58 0.54 0.69 0.96 Inventory Days 79.52 81.27 79.28 81.18 65.97 Payable days 21.33 25.98 24.13 28.76 24.12 Cash Conversion Cycle 59.03 55.87 55.69 53.10 42.81 Total Debt/Equity 0.00 0.00 0.10 0.20 0.36 Interest Cover 1.65 1.48 2.42 2.41 1.63

Top Investors:

nippon life india trustee ltd-a/c nippon india mul

pi opportunities fund i

sbi long term equity fund

icici prudential pharma healthcare and diaganostic

arisaig asia fund limited

pravesa holding private limited

government of singapore

hdfc life insurance company limited

goldman sachs funds - goldman sachs india equity p

Annual Reports:

News Update:

Medplus Health Servi - Quarterly Results
2nd Aug 2024, 17:36 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback